معرفی
Professor Carolin Wendling is a faculty member at the Graduate School Life Science Munich, Ludwig-Maximilians-University Munich (LMU), where she leads the Medical Microbiology research group. Her work focuses on bacterial evolution, mobile genetic elements, and phage therapy applications in gut infections.
- Professor for Medical Microbiology, LMU (2024–present)
- W2 Professorship, Max von Pettenkofer Institute (2024–present)
- Research Group Leader, ETH Zurich (2019–2024)
- Postdoctoral Fellowships, University of Kiel, University of York, University of Zurich
Her research explores how phage-bacteria interactions shape antimicrobial resistance, virulence, and gut health. Key projects include prophage dynamics in microbial communities and optimization of phage therapy strategies. She employs molecular biology, genomics, and mathematical modeling across clonal populations to complex ecosystems.
Recent publications highlight her expertise in prophage-mediated genetic transfer, environmental influences on phage epidemics, and Vibrio pathogen evolution. Her work has been recognized through competitive fellowships like the SNSF Ambizione grant.
- Prophage maintenance mechanisms (Current Biology, 2024)
- Phage therapy optimization (Current Opinion in Systems Biology, 2023)
- Plasmid-phage interactions (Phil Trans B, 2022)
- Vibrio genomics and adaptation (Microbial Genomics, 2022)
As a mentor, she supervises PhD and Master’s students while leading a multidisciplinary team integrating experimental and computational approaches to microbial evolution.
